1)- Alexandra Z Sosinsky, Yufei Song, Lhanoo Gunawardhana, Syd Phillips, Matt Page. The Impact of Label Changes (Boxed Warning) on Real-World Febuxostat Utilization in Patients with Gout: A Cross-Sectional Drug Utilization Study.Rheumatology and therapy. 2023, 10 (5): 1277-1295
2)- Olivier Bruyere, Germain Honvo, Eduard Vidovic, Bernard Cortet. Is the Rate of Responders to Hyaluronic Acid Injection for Patients with Knee Osteoarthritis Stable Over Time? Post hoc Analyses of a 6-Month Follow-Up Study.Rheumatology and therapy. 2023, 10 (5): 1297-1303
3)- Jacob N Hunnicutt, Mary Elizabeth Georgiou, Liyuan Ma, Roger A Levy, Kerry Gairy. Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States.Rheumatology and therapy. 2023, 10 (5): 1305-1318
4)- Beatriz Joven, Raquel Hernández Sánchez, Eva Pérez-Pampín, Ángel Aragón Díez, Raquel Almodóvar, Ángels Martínez-Ferrer, Joaquín Belzunegui, Esteban Rubio, Silvia Díaz-Cerezo, Sebastián Moyano, Manuel Gómez-Barrera, María Yébenes, Mercedes Núñez. Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study.Rheumatology and therapy. 2023, 10 (5): 1319-1333
5)- Yoshiya Tanaka, Peter C Taylor, Emon Elboudwarej, Angie Hertz, Xiaorong Shao, Vladislav A Malkov, Hironori Matsushima, Kahaku Emoto, Bryan Downie, Tsutomu Takeuchi. Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate.Rheumatology and therapy. 2023, 10 (5): 1335-1348
6)- Yvonne M van der Kraan, Davy Paap, Niels Lennips, Else C A Veenstra, Freke R Wink, Stan C Kieskamp, Anneke Spoorenberg. Patients' Needs Concerning Patient Education in Axial Spondyloarthritis: A Qualitative Study.Rheumatology and therapy. 2023, 10 (5): 1349-1368
7)- Juan Xiao, Fengqiao Zhou, Zhenwang Zhao, Fengsheng Cao, Hong Xiao, Lu Zhang, Huabo Chen, Ke Wang, Anbing Zhang. PDCD5 as a Potential Biomarker for Improved Prediction of the Incidence and Remission for Patients with Rheumatoid Arthritis.Rheumatology and therapy. 2023, 10 (5): 1369-1383
8)- Jessica A Walsh, Christopher D Saffore, Eric B Collins, Andrew Ostor. Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis.Rheumatology and therapy. 2023, 10 (5): 1385-1398